ArticleJournal of the American Society of Nephrology : JASN2025
Authors' Reply: Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.
Vikas S Sridhar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.